Journal List > Korean J Endocr Surg > v.11(3) > 1060032

M.D., M.D, and M.D: Complication after Total Thyroidectomy and Node Dissection for Thyroid Cancer

Abstract

Purpose:

The typical complications after thyroidectomy are bleeding, hematoma, hoarseness, hypocalcemia, chylous fistula, etc. The aim of this study was to determine the incidence and to evaluate risk factors of complication after total thyroidectomy and lymph node dissection (ND) for thyroid cancer.

Methods:

We performed a retrospective review of 623 patients with thyroid cancer and who underwent total thyroidectomy and ND and the patients were treated at our hospital from March 2007 to February 2010. The clinical features of complications were reviewed and the incidence and predisposing factors of the complication were analyzed.

Results:

Postoperative bleeding occurred in 0.2% of the patients. The overall incidence of transient and permanent hypocalcemia was 8.5% and 0.6%, respectively. Graves disease, a decreased number of preserved parathyroid glands and an increased number of removed central lymph nodes constituted the risk factors for postoperative hypocalcemia. On multivariate logistic regression analysis, the presence of Graves disease and a decreased number of preserved parathyroid glands were the independent risk factors for postoperative hypocalcemia. Hoarseness occurred in 1.6% of the patients. The incidence of chylous fistula after lymph node dissection in the central neck and lateral neck was 0.5% and 0.3%, respectively.

Conclusion:

Total thyroidectomy with ND is a safe procedure because the overall incidence of postoperative complications is low. Careful surgery is required for thyroid cancer patients with Graves disease. Parathyroid gland insufficiency is the important cause of hypocalcemia after to-tal thyroidectomy and ND. To reduce voice change, careful dissection is required around the recurrent laryngeal nerve and excessive tracheal traction should be avoided.

REFERENCES

1.Shaha AR., Jaffe BM. Parathyroid preservation during thyroid surgery. Am J Otolaryngol. 1998. 19:113–7.
crossref
2.Cheah WK., Arici C., Ituarte PH., Siperstein AE., Duh QY., Clark OH. Complications of neck dissection for thyroid cancer. World J Surg. 2002. 26:1013–6.
crossref
3.Thomusch O., Machens A., Sekulla C., Ukkat J., Brauckhoff M., Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003. 133:180–5.
crossref
4.McHenry CR., Speroff T., Wentworth D., Murphy T. Risk factors for postthyroidectomy hypocalcemia. Surgery. 1994. 116:641–7.
5.Demeester-Mirkine N., Hooghe L., Van Geertruyden J., De Maertelaer V. Hypocalcemia after thyroidectomy. Arch Surg. 1992. 127:854–8.
crossref
6.Kark AE., Kissin MW., Auerbach R., Meikle M. Voice changes after thyroidectomy: role of the external laryngeal nerve. Br Med J (Clin Res Ed). 1984. 289:1412–5.
crossref
7.Crumley RL., Smith JD. Postoperative chylous fistula prevention and management. Laryngoscope. 1976. 86:804–13.
crossref
8.de Gier HH., Balm AJ., Bruning PF., Gregor RT., Hilgers FJ. Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck. 1996. 18:347–51.
crossref
9.Park JD., Hong SJ. Chylous fistula after surgery for papillary thyroid carcinoma. Korean J Endocrine Surg. 2002. 02:109–15.
crossref
10.Shaha AR., Jaffe BM. Practical management of post-thyroidectomy hematoma. J Surg Oncol. 1994. 57:235–8.
crossref
11.Godballe C., Madsen AR., Pedersen HB., Sørensen CH., Pedersen U., Frisch T, et al. Post-thyroidectomy hemorrhage: a national study of patients treated at the Danish departments of ENT Head and Neck Surgery. Eur Arch Otorhinolaryngol. 2009. 266:1945–52.
crossref
12.Farrar WB., Cooperman M., James AG. Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg. 1980. 192:701–4.
crossref
13.Wingert DJ., Friesen SR., Iliopoulos JI., Pierce GE., Thomas JH., Hermreck AS. Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg. 1986. 152:606–10.
14.Attie JN., Moskowitz GW., Margouleff D., Levy LM. Feasibility of total thyroidectomy in the treatment of thyroid carcinoma: postoperative radioactive iodine evaluation of 140 cases. Am J Surg. 1979. 138:555–60.
15.Lal G., Ituarte P., Kebebew E., Siperstein A., Duh QY., Clark OH. Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid. 2005. 15:569–74.
crossref
16.Pesce CE., Shiue Z., Tsai HL., Umbricht CB., Tufano RP., Dackiw AP, et al. Postoperative hypocalcemia after thyroidectomy for Graves' disease. Thyroid. 2010. 20:1279–83.
crossref
17.Attie JN., Khafif RA. Preservation of parathyroid glands during total thyroidectomy. Improved technic utilizing microsurgery. Am J Surg. 1975. 130:399–404.
18.Horsley J. Suture of the recurrent laryngeal nerve with report of a case. Trans South Surg Gynecol Assoc. 1909. 22:161–7.
crossref
19.Paniello RC. Laryngeal reinnervation. Otolaryngol Clin North Am. 2004. 37:161–81.
crossref
20.Thawley SE. "How I do it"–head and neck. A targeted problem and its solution. Chylous fistula prevention and management. Laryngoscope. 1980. 90:522–5.
21.Mallen RW., Kudryk WH. Case report: Chylous fistula following right radical neck dissection. Can J Otolaryngol. 1975. 4:177–9.
22.Lucente FE., Diktaban T., Lawson W., Biller HF. Chyle fistula management. Otolaryngol Head Neck Surg. 1981. 89:575–8.
crossref
23.Nussenbaum B., Liu JH., Sinard RJ. Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg. 2000. 122:31–8.
crossref

Table 1.
Clinicopathologic characteristics of the patients
Sex (M:F) 91:532 (14.6%:85.4%)
Age (years) 45.85±10.99 (18∼74)
 <45 295 (47.4%)
 ≥45 328 (52.6%)
Presence of Graves’ disease 26 (3.9%)
Operation  
 Total thyroidectomy+CLND 568 (91.2%)
 Total thyroidectomy+MRND 55 (8.8%)
Diagnosis  
Papillary thyroid cancer 616 (98.9%)
Follicular thyroid caner 5 (0.8%)
Medullary thyroid cancer 2 (0.3%)
Mass size (cm) 1.07±0.82 (0.2∼7)
Multifocality  
 Single 407 (65.3%)
 Multiple (≥2) 216 (34.7%)
Extrathyroid extension  
 No 254 (40.8%)
 Yes 369 (59.2%)
Thyroiditis  
No 474 (76.1%)
Yes 149 (23.9%)
Removed central lymph node 11.6±26.52 (1∼53)
T stage  
 T1 241 (38.7%)
 T2 11 (1.8%)
 T3 312 (50.1%)
 T4a 57 (9.1%)
T4b 2 (0.3%)
N stage  
 No 310 (49.8%)
N1a 262 (42.1%)
N1b 51 (8.2%)

CLND = central lymph node dissection; MRND = modified radical neck dissection.

Fig. 1
Preserved parathyroid gland with intact blood supply.
kjes-11-169f1.tif
Table 2.
Clinical features and incidences of complication after total thyroidectomy and lymph node dissection
  Number of patients (%)
Bleeding 1 (0.2%)
Hypocalcemia 57 (9.1%)
Transient 53 (8.5%)
Permanent 4 (0.6%)
Hoarseness  
Transient 9 (1.4%)
Permanent 1 (0.2%)
Chylous fistula  
Central 3 (0.5%)
Lateral 2 (0.3%)
Table 3.
Univariate analysis of clinicopathologic characteristics in postoperative hypocalcemia
Variable Normocalcemia Hypocalcemia P value
Sex (M:F)     NS
Male 84 (92.3%) 7 (7.7%)  
Female 482 (90.6%) 50 (9.4%)  
Age (years) 45.72±11.09 47.19±10.08 NS
Presence of     0.016
Graves’ disease      
No 548 (91.5%) 51 (8.5%)  
Yes 18 (75.0%) 6 (25.0%)  
Operation     NS
Total thyroidectomy 517 (91.0%) 51 (9.0%)  
Total thyroidectomy+ 49 (89.1%) 6 (10.9%)  
MRND      
Diagnosis     NS
Papillary thyroid cancer 559 (90.7%) 57 (9.3%)  
Follicular thyroid caner 5 (100.0%) 0 (0.0%)  
Medullary thyroid cancer 2 (100.0%) 0 (0.0%)  
Mass size (cm) 1.06±0.77 1.24±1.18 NS
Multifocality     NS
Single 368 (90.4%) 39 (9.6%)  
Multiple (≥2) 198 (91.7%) 18 (8.3%)  
Extrathyroid extension     NS
No 236 (92.9%) 18 (7.1%)  
Yes 330 (89.4%) 39 (10.6%)  
Thyroiditis     NS
No 436 (92.0%) 38 (8.0%)  
Yes 130 (87.2%) 19 (12.8%)  
No. of identified 3.07±0.83 2.88±1.02 NS
parathyroid glands      
No. of preserved 1.78±0.98 0.68±0.78 <0.001
parathyroid glands      
Removed central lymph 11.40±6.30 13.81±8.12 0.033
node      
Number of central lymph 1.60±2.58 1.89±3.61 NS
node metastasis      
T stage     NS
Less than T2 234 (92.9%) 18 (7.1%)  
More than T3 332 (89.5%) 39 (10.5%)  

MRND = modified radical neck dissection.

Table 4.
Multivariate analysis of clinicopathologic characteristics in postoperative hypocalcemia
Variable Odds ratio 95% confidence interval P value
Sex (M:F) 1.426 0.572∼3.558 NS
Age (years) 1.016 0.989∼1.044 NS
Presence of 3.520 1.112∼11.140 0.032
Graves’ disease      
No. of preserved 0.222 0.147∼0.336 <0.001
parathyroid glands      
Removed central lymph node 1.032 0.991∼1.074 0.127
Table 5.
Incidence of hypocalcemia regarding to number of preserved parathyroid glands in four parathyroid glands identified groups
Number of preserved parathyroid glands Total (n=202) Number of transient hypocalcemia (%)
1 42 5 (11.9%)
2 78 6 (7.7%)
3 57 0 (0.0%)
4 25 0 (0.0%)
Fig. 2
Thoracic duct.
kjes-11-169f2.tif
TOOLS
Similar articles